Principal ML Scientist – Predictive Toxicology

About Apheris At Apheris, we power federated data networks in life sciences to enable the development of machine learning models that outperform what any single organisation can build alone. Biopharma can only synthesise and test a finite number of compounds across assays, structural biology workflows, and complex ADME and toxicity endpoints, limiting the performance of models trained on in-house data. The Apheris product addresses this by hosting networks where biopharma organisations collabor…